| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Lesigercept | YH-35324; GI-301 | Phase 2 Clinical | Yuhan Corp | Chronic Urticaria; Hypersensitivity; Immune System Diseases; Urinary Tract Infections; Urticaria | Details |
| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Benzylpenicilloyl Polylysine | Approved | Allerquest Llc | Pre-pen | United States | Anaphylaxis; Diagnostic agents | Allerquest Inc | 1974-07-25 | Anaphylaxis; Diagnostic agents | Details |